Barclays Reaffirms “Neutral” Rating for AXA (EPA:CS)

Barclays reissued their neutral rating on shares of AXA (EPA:CS) in a report released on Wednesday, Borsen Zeitung reports.

Other analysts also recently issued reports about the stock. Deutsche Bank set a €25.00 ($29.07) price objective on shares of AXA and gave the company a buy rating in a research report on Friday, August 2nd. Nord/LB set a €27.00 ($31.40) price objective on shares of AXA and gave the company a buy rating in a research report on Tuesday, August 27th. Morgan Stanley set a €26.70 ($31.05) price objective on shares of AXA and gave the company a buy rating in a research report on Tuesday, August 6th. Goldman Sachs Group set a €27.50 ($31.98) price objective on shares of AXA and gave the company a buy rating in a research report on Thursday, August 1st. Finally, HSBC set a €30.70 ($35.70) price objective on shares of AXA and gave the company a neutral rating in a research report on Monday, June 3rd. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. AXA presently has an average rating of Buy and an average target price of €26.74 ($31.09).

Shares of EPA:CS opened at €22.74 ($26.44) on Wednesday. The firm has a 50-day moving average price of €22.01. AXA has a fifty-two week low of €22.13 ($25.73) and a fifty-two week high of €27.69 ($32.20).

AXA Company Profile

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

See Also: Are FAANG stocks a good investment?

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.